An editorial appearing in vol 3 no 1 of the journal Ethical Human Sciences and Services in which Dr. Breggin points out that the kind of research used to justify a ban on MDMA (the recreational drug Ecstasy) could also be used to justify a ban of SSRI antidepressants. fromprozac.pbreggin.2001.pdf
Read More
Report presented at the September 14, 2004 press conference sponsored by the Alliance for Human Research Protection (AHRP) at the FDA Public Hearing on Antidepressants and Suicide. fdapressconfsept142004.pdf
Read More
A report Dr. Breggin presented to the FDA in August 2004 detailing the relation of suicidality and violence to antidepressants fdaaug2304.pdf
Read More
Dangers of antidepressants. Newspaper column–shortened.pdf
Read More
SSRIs produce a continuum of stimulation that includes manic-like reactions, agitated depression, obsessive preoccupations, and akathisia. FDAspeech2.2.04.pdf
Read More
Ethical Human Psychology and Psychiatry, 7, 7-22, 2004. Simultaneously published in the International Journal of Risk and Safety in Medicine, 16, 247-259, 2005. recentus.pbreggin.2004.pdf
Read More